Abstract
Editorial Comment: Reduction in Calcineurin Inhibitor Exposure and Maintenance of Effective Immunosuppression: Clinical Experience with Everolimus (Certican)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have